AAON keeps its cool with 30% year-to-date stock gain
AAON CEO Gary Fields discusses how extreme weather events and the commercial real estate downturn are affecting the HVAC solutions company on 'The Claman Countdown.'
Southwest Airlines reaches tentative agreement with Teamsters on new contract for material specialists
Southwest Airlines and the International Brotherhood of Teamsters announced a tentative agreement on a new contract for more than 480 material specialists.
SoftBank’s Arm targets $52B valuation in 2023's biggest IPO
SoftBank is offering 95.5 million American depository shares of Arm for $47 to $51 each and is aiming to pull in $4.87 billion on the high end, according to a regulatory filing.
Bull market is alive, look out for a surprise September rally: Ryan Detrick
Carson Group chief market strategist Ryan Detrick and UBS Wealth Management Senior Vice President Brenda O’Connor Juanas provide their stock market outlooks for September on 'Mornings with Maria.'
Investors should stick to short-term bonds as rates rise: Katy Kaminski
AlphaSimplex portfolio manager Katy Kaminski discusses whether another Fed rate hike will harm the markets on 'The Claman Countdown.'
Labor Day, GameStop and Kroger earnings and Goldman’s technology conference top week ahead
After the Labor Day holiday, investors will kick off the first week of September with a host of earnings and Goldman's technology conference featuring the world's biggest AI players.
Buying a house for many Americans is harder to achieve as prices continue to climb
National Association of Realtors chief economist Lawrence Yun weighs in as rising home prices squeeze prospective buyers on 'Maria Bartiromo's Wall Street.'
AI will impact 'everything,' businesses not adapting won't exist: Keith Fitz-Gerald
Geltrude & Company founder Dan Geltrude and The Fitz-Gerald Group principal Keith Fitz-Gerald discuss how the August jobs report could affect Fed rate hikes and the impact of A.I. on 'The Claman Countdown.'
Bitcoin ETF approval will drive crypto adoption in the US: Brandon Mintz
Bitcoin Depot CEO Brandon Mintz discusses the benefits of converting cash into crypto on 'The Claman Countdown.'
Amgen gets green light from FTC for $27.8B Horizon Therapeutics deal
The Federal Trade Commission will allow Amgen to continue a $27.8 billion purchase of Horizon Therapeutics. The companies anticipate closing the deal in the fourth quarter.
Dell shares jump on raised forecast fueled by AI and hardware sales
Shares of Dell Technologies are up on Friday after the company said it was lifting its full year forecast for revenue and profit amid an AI boom and steady demand for computer hardware.
Fed might pass on rate hikes for rest of the year: Tim Anderson
NYSE trader Tim Anderson discusses the condition of the U.S. labor market as inflation seems to have stabilized on 'Cavuto: Coast to Coast.'
Robinhood to buy back Bankman-Fried's stake from US government for $605.7M
The shares of Robinhood were seized and subsequently transferred to the custody of the U.S. government after Bankman-Fried's FTX and Emergent filed for bankruptcy protection last year.
Uber could be added to the S&P 500 in next 12 months: Mark Mahaney
Evercore ISI senior managing director Mark Mahaney explains his Chewy downgrade and why investors should be adding Uber to their portfolios on 'Varney & Co.'
Former NFL player Brandon Copeland teaches the importance of financial literacy
Former NFL player Brandon Copeland discusses the league's move to streaming services and his push to financially educate players on 'The Claman Countdown.'
Market expert recommends putting new money to work in AI sector
FinTec AI CEO Wolfgang Koester previews August's last day of trading and economic data.
Pot stocks rally after health officials ask DEA to reclassify marijuana as lower-risk drug
Assistant Secretary for Health Rachel Levine reportedly requested in a letter to DEA Administrator Anne Milgram that marijuana be downgraded to a schedule III substance.
Grayscale's win over SEC is a 'tremendous victory' for crypto: CEO Michael Sonnenshein
Grayscale Investments CEO Michael Sonnenshein discusses the possibility of a Bitcoin ETF after his victory over the SEC on 'The Claman Countdown.'
Cencora is central to healthcare economies: CEO Steven Collis
Cencora Chairman and President Steven Collis discusses the world of Big Pharma after the Biden administration named 10 high-cost drugs for Medicare price negotiations on 'The Claman Countdown.'
Bitcoin spot ETF approval is inevitable: Christopher Alexander
Pioneer Development Group chief analytics officer Christopher Alexander discusses Grayscale Investments' win over the SEC for approval of a Bitcoin ETF on 'The Big Money Show.'